Finance
Market Analysts see Blueprint Medicines Corp [BPMC] gaining to $129. Time to buy?
Blueprint Medicines Corp [NASDAQ: BPMC] closed the trading session at $127.97. The stocks have a year to date performance of 46.72 percent and weekly performance of 0.29 percent. The stock has been moved at 34.59 percent over the last six months. The stock has performed
